Hologic Slashes Annual Revenue Forecast Amid Soft Demand for Breast Health Products
2025-02-05
Reuters on MSN.com
Hologic has reduced its fiscal 2025 revenue forecast due to declining sales of its breast health products, resulting in a 5% drop in the company's shares after hours on Wednesday. This revision reflects a significant shift in the medical device industry, particularly in the breast cancer screening and diagnostic markets. As a leading provider of women's health solutions, Hologic's adjusted forecast may impact the overall growth of the healthcare technology sector, including digital mammography and breast imaging systems. Key market trends, such as the adoption of artificial intelligence in healthcare and personalized medicine, are expected to influence the company's future prospects.
